Understanding your risk of Peripheral Artery Disease (PAD)

Peripheral Artery Disease (PAD) occurs when narrowed blood vessels reduce blood flow to your arms and legs. The reduced circulation can cause pain, sores and other dysfunction in your limbs. Heart disease and diabetes are significant risk factors for PAD.
If you are managing cardiovascular issues or diabetes, you should understand your risk of PAD.

Risk Calculator

Select the most applicable option to assess your risk for PAD:

Age
Gender
Race*
Systolic Blood Pressure (mmHg)
HDL Cholesterol (mg/dL) click on units to change between mg/dL and mmol/L
Total Cholesterol (mg/dL) click on units to change between mg/dL and mmol/L
Diabetes
Smoking Status
History of Cardiovascular Disease

* The underlying risk assessment was performed by researchers at Johns Hopkins University on a population of white, black and hispanic patients. Talk to your doctor to ensure your PAD risk is being assessed appropriately given your personal demographic information.

Results

Overall risk of PAD:

________

Prevalence of PAD:

________

Prevalence refers to the expected percent of people with matching characteristics that have PAD

Next Steps

Based on your inputs, we suggest talking with your doctor about your risk factors for PAD.

The underlying model was developed by clinical researchers at Johns Hopkins University School of Medicine using data from six US community-based cohorts including the National Health and Nutrition Examination Surveys as well as the US mortality rate from Vital Statistics to estimate the prevalence and 1-year risk of developing PAD, defined as an ankle-brachial index (ABI) < 0.90, at each year of age from birth to 80 years for White, Black, and Hispanic men and women. Markov Monte Carlo simulations in a simulated cohort of 100,000 individuals were then used to estimate lifetime risk of PAD. Prevalence and residual lifetime risk of PAD according to combinations of traditional atherosclerotic risk factors above, were developed based on odds ratios of PAD.